Attention Deficit Hyperactivity Disorder
Conditions
Keywords
cognitive-behavioral therapy, adolescents, ADHD.
Brief summary
This is the first randomized controlled study that tests the efficacy of a cognitive-behavioral group therapy (CBT) on adolescents with ADHD who were in pharmacological treatment but still presented persistent symptoms.
Detailed description
A multicenter, randomized rater-blinded controlled trial was carried out in a sample of 119 adolescents (15-21 years) and was conducted between April 2012- May 2014. Patients were randomly assigned to 12 group manualized cognitive-behavioural group therapy sessions (n=45) or a waiting list control group (N=44). Primary outcomes were assessed by a blind evaluator (ADHD Rating Scale, Clinical Global Impression Scale for Severity, Global Assessment Functioning) before and after treatment as well as by self-report and parent informant ratings.
Interventions
methylphenidate or atomoxetine
BEHAVIORALCBT group
Sponsors
Hospital Universitari Vall d'Hebron Research Institute
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
15 Years to 21 Years
Healthy volunteers
No
Inclusion criteria
* DSM-IV ADHD diagnosis * age between 15 and 21 years * stabilized doses of medication for ADHD for at least 2 months prior to the study * agreement not to seek out any other psychiatric or psychological treatment during the study.
Exclusion criteria
* affective disorders * anxiety disorders * psychotic disorders * personality disorders * substance use disorders in the past 6 months * pervasive developmental disorder * patients with an IQ lower than 85 * patients receiving concurrent psychological interventions.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Post-treatment ADHD symptoms | Post-treatment (after receiving 3 month treatment) | measured by ADHD Rating Scale (clinician-administered version for the adolescent and also parent informant). It is a 18 item scale which assesses the diagnostic criteria for ADHD and rates the frequency of each item on a 4 point Likert scale. |
| Post-treatment functional impairment | Post-treatment (after receiving 3 month treatment) | Assessed by Weiss Functional Impairment Scale (WFIRS) self report and parent version (an appropriate measure for functional impairment associated with ADHD) and by GAF (Global Assessment of Functioning) evaluated by a blinded rater. It is a clinician-administered measure to assess clinical severity and functioning. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Post-treatment depression symptoms | Post-treatment (after receiving 3 month treatment) | assessed by Beck Inventory Depression Scale (BDI). It is a 21 item scale to test depression symptoms where respondents rate how they have been feeling during the past week on a 4 point Likert scale (0-3) |
| Post-treatment anxiety symptoms | Post-treatment (after receiving 3 month treatment) | assessed by State-Trait Anxiety Inventory. It is a 40 item scale. It differentiates between the temporary condition of state anxiety and the more general and long-standing quality of trait anxiety. |
| Post-treatment anger management | Post-treatment (after receiving 3 month treatment) | State-Trait Anger Expression Inventory-2 (STAXI-2)was used for patients between 16-21 years and STAXI-NA for 15 years-old patients. The STAXI-2 is a self-report questionnaire that measures state anger, trait anger, expression and control of anger |
Countries
Spain
Outcome results
None listed